Inositol nicotinate
Chemical compound
- C04AC03 (WHO)
- US: OTC
- cyclohexane-1,2,3,4,5,6-hexayl hexanicotinate
- 6556-11-2
- 3720
- 16736141
- A99MK953KZ
- D01813
- DTXSID2023147
- Interactive image
- O=C(O[C@H]6[C@H](OC(=O)c1cccnc1)[C@H](OC(=O)c2cccnc2)[C@H](OC(=O)c3cccnc3)[C@@H](OC(=O)c4cccnc4)[C@@H]6OC(=O)c5cccnc5)c7cccnc7
Inositol nicotinate, also called inositol hexanicotinate and inositol hexaniacinate, is marketed in the United States as a "no-flush niacin" dietary supplement.[1] Flushing, in physiology, essentially means that epidermal tissues have become reddened, such as when the skin is irritated from the histamine responses related to an allergic reaction, or from recent physical exercise, or even from anger or embarrassment.
This form of niacin is supposed to reduce or prevent flushing by being broken down into the metabolites niacin (nicotinic acid) and inositol at a slow rate.[1]
See also
- Esterification
- Hydrolysis
References
- ^ a b Taheri R (15 January 2003). "No-Flush Niacin for the Treatment of Hyperlipidemia". Medscape.com. Retrieved 14 September 2010.
- v
- t
- e
- Non-selective
- Selective α1-blockers
- Niacin
- Nicotinyl alcohol
- Inositol nicotinate
- Ciclonicate
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e